Stay updated with breaking news from Choice Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NANOBIOTIX Announces First Patient Randomized in the United States in Global Phase 3 Pivotal Trial Evaluating Radioenhancer NBTXR3 in Head and Neck Cancer - read this article along with other careers information, tips and advice on BioSpace
Regional activation for Nanobiotix pivotal Phase 3 trial in head and neck cancer proceeds as planned with first patient enrolled in Asia by partner LianBioThe collaboration continues to build momentum behind LianBio’s leadership in Asia while Nanobiotix remains focused on enrollment globallyPARIS & CAMBRIDGE, Mass....
Regional activation for Nanobiotix pivotal Phase 3 trial in head and neck cancer proceeds as planned with first patient enrolled in Asia by partner LianBio The collaboration continues to build
NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer - read this article along with other careers information, tips and advice on BioSpace